U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H33N2O.Br
Molecular Weight 433.425
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOPROPAMIDE BROMIDE

SMILES

[Br-].CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C

InChI

InChIKey=UHDXPMNTVNTHJT-UHFFFAOYSA-N
InChI=1S/C23H32N2O.BrH/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21;/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26);1H

HIDE SMILES / InChI
Isopropamide is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Originator

Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/isopropamide-iodide.html

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DARBID

Approved Use

Isopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Launch Date

1957
Primary
DARBID

Approved Use

Isopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Launch Date

1957
Doses

Doses

DosePopulationAdverse events​
40 mg single, oral (max)
MTD
Dose: 40 mg
Route: oral
Route: single
Dose: 40 mg
Sources: Page: p.537
unhealthy, 27-53
n = 7
Health Status: unhealthy
Condition: Duodenal ulcer
Age Group: 27-53
Sex: M+F
Population Size: 7
Sources: Page: p.537
PubMed

PubMed

TitleDatePubMed
Derivative spectrophotometric, thin layer chromatographic-densitometric and high performance liquid chromatographic determination of trifluoperazine hydrochloride in presence of its hydrogen peroxide induced-degradation product.
2002 Jan 1
Simultaneous RP-HPLC Estimation of Trifluoperazine Hydrochloride and Chlordiazepoxide in Tablet Dosage Forms.
2009 Sep
Spectrophotometric determination of isopropamide iodide and trifluoperazine hydrochloride in presence of trifluoperazine oxidative degradate.
2010 Apr
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.
2010 Dec
2-Hydroxy-N,N'-diisopropylpropane-1,3-diaminium dichloride.
2010 Jun 23
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
ISOPROPAMIDE BROMIDE
WHO-DD  
Common Name English
Isopropamide bromide [WHO-DD]
Common Name English
BENZENEPROPANAMINIUM, .GAMMA.-(AMINOCARBONYL)-N-METHYL-N,N-BIS(1-METHYLETHYL)-.GAMMA.-PHENYL-, BROMIDE
Systematic Name English
NEOPANT
Brand Name English
Code System Code Type Description
EPA CompTox
DTXSID30168001
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY
SMS_ID
100000086439
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY
PUBCHEM
27927
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY
CAS
16564-41-3
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY
EVMPD
SUB02800MIG
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY
FDA UNII
4Z84BE98DY
Created by admin on Fri Dec 15 18:44:38 GMT 2023 , Edited by admin on Fri Dec 15 18:44:38 GMT 2023
PRIMARY